Spots Global Cancer Trial Database for adult acute myeloblastic leukemia without maturation (m1)

Every month we try and update this database with for adult acute myeloblastic leukemia without maturation (m1) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia	NCT00002549	Leukemia	filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera...	15 Years - 60 Years	National Cancer Institute (NCI)
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia	NCT00004128	Leukemia	aldesleukin filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide autologous bone... peripheral bloo... radiation thera...	15 Years - 60 Years	National Cancer Institute (NCI)
Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission	NCT00070135	Adult Acute Mye... Acute Myeloid L...	filgrastim Anti-Thymocyte ... busulfan fludarabine pho... methotrexate tacrolimus Allogeneic Hema...	60 Years - 74 Years	Alliance for Clinical Trials in Oncology
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531	NCT01407757	Leukemia	DNA analysis gene expression... laboratory biom... pharmacogenomic...	- 29 Years	Children's Oncology Group
Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia	NCT00089050	Leukemia	cyclosporine gemtuzumab ozog...	60 Years -	Fred Hutchinson Cancer Center
Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia	NCT00818649	Leukemia Myelodysplastic...	bortezomib vorinostat	18 Years -	Masonic Cancer Center, University of Minnesota
Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia	NCT00101231	Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Blastic Phase C... Recurrent Adult... Recurrent Adult... Relapsing Chron...	alvocidib	1 Year -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia	NCT00002588	Leukemia	etoposide topotecan hydro...	18 Years -	Case Comprehensive Cancer Center
Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia	NCT00093483	Leukemia	filgrastim arsenic trioxid... cytarabine idarubicin	18 Years - 59 Years	Roswell Park Cancer Institute
S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia	NCT00066794	Leukemia	filgrastim sargramostim cyclosporine cytarabine daunorubicin hy...	56 Years -	SWOG Cancer Research Network
Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia	NCT01159301	Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Blastic Phase C... Recurrent Adult... Unspecified Adu...	entinostat sorafenib tosyl... pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia	NCT00602771	Acute Myeloid L... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult...	tipifarnib etoposide	70 Years -	National Cancer Institute (NCI)
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission	NCT00002768	Leukemia	filgrastim busulfan cytarabine etoposide methotrexate peripheral bloo...	15 Years - 69 Years	Alliance for Clinical Trials in Oncology
S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00004217	Leukemia	filgrastim sargramostim cytarabine daunorubicin hy... valspodar	56 Years -	SWOG Cancer Research Network
Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission	NCT00101140	Adult Acute Ery... Adult Acute Mon... Adult Acute Mye...	anti-thymocyte ... fludarabine pho... thiotepa biological ther... bone marrow abl... chemotherapy non-specific im... peripheral bloo... radiation thera...	18 Years - 59 Years	Eastern Cooperative Oncology Group
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00003268	Drug/Agent Toxi... Leukemia	amifostine trih... cytarabine idarubicin	18 Years -	National Cancer Institute (NCI)
S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia	NCT01338974	Leukemia	gene expression... proteomic profi... flow cytometry laboratory biom...	56 Years -	SWOG Cancer Research Network
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia	NCT00003758	Leukemia	cytarabine idarubicin allogeneic bone... autologous bone... peripheral bloo...	15 Years - 60 Years	National Cancer Institute (NCI)
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia	NCT00528398	Leukemia	cytarabine idarubicin	16 Years - 60 Years	City of Hope Medical Center
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia	NCT00004215	Anemia Leukemia Neutropenia Thrombocytopeni...	filgrastim leridistim cytarabine daunorubicin hy...	55 Years -	Memorial Sloan Kettering Cancer Center
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia	NCT00006122	Leukemia	cytarabine etoposide gemtuzumab ozog... idarubicin mitoxantrone hy...	61 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	NCT00634244	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult...	alvocidib mitoxantrone hy... carboplatin cytarabine sirolimus etoposide topotecan hydro...	18 Years - 65 Years	National Cancer Institute (NCI)
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00112853	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult...	tipifarnib etoposide	70 Years -	National Cancer Institute (NCI)
Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT01349972	Acute Myeloid L... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult...	alvocidib daunorubicin hy... mitoxantrone hy... cytarabine	18 Years - 70 Years	National Cancer Institute (NCI)
Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy	NCT01169363	Leukemia	proteomic profi... flow cytometry laboratory biom...	60 Years - 120 Years	Eastern Cooperative Oncology Group
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy	NCT01235572	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Previously Trea... Recurrent Adult...	standard follow... medical chart r... quality-of-life...	18 Years - 75 Years	Fred Hutchinson Cancer Center
Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R	NCT00534469	Leukemia	aldesleukin filgrastim busulfan cytarabine etoposide idarubicin autologous hema... bone marrow tra... peripheral bloo... total-body irra...	16 Years - 60 Years	City of Hope Medical Center
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia	NCT01839240	Adult Acute Meg... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... Secondary Acute... Untreated Adult...	azacitidine cytarabine mitoxantrone hy... laboratory biom...	18 Years -	University of Chicago
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia	NCT00899743	Leukemia	polyacrylamide ... western blottin... immunologic tec... laboratory biom...	56 Years -	SWOG Cancer Research Network
Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia	NCT00027872	Acute Myeloid L... Adult Acute Bas... Adult Acute Eos... Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Cellular Diagno... Untreated Adult...	tipifarnib laboratory biom...	65 Years -	National Cancer Institute (NCI)
Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia	NCT00742625	Acute Myeloid L... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Untreated Adult...	daunorubicin hy... cytarabine bortezomib	60 Years - 75 Years	National Cancer Institute (NCI)
VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia	NCT00354276	Leukemia	cytarabine laromustine	60 Years -	National Cancer Institute (NCI)
Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia	NCT00742625	Acute Myeloid L... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Untreated Adult...	daunorubicin hy... cytarabine bortezomib	60 Years - 75 Years	National Cancer Institute (NCI)
Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia	NCT00268229	Leukemia	cytarabine daunorubicin hy... imatinib mesyla...	18 Years -	The Cleveland Clinic
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes	NCT00454480	Leukemia Myelodysplastic...	alemtuzumab arsenic trioxid... azacitidine busulfan clofarabine cytarabine daunorubicin hy... fludarabine pho... gemtuzumab ozog... melphalan tipifarnib DNA methylation... cytogenetic ana... gene expression... mutation analys... diagnostic labo... immunologic tec... allogeneic hema... nonmyeloablativ...	-	National Cancer Institute (NCI)
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia	NCT00002549	Leukemia	filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera...	15 Years - 60 Years	National Cancer Institute (NCI)
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00651261	Leukemia	cytarabine daunorubicin midostaurin placebo dexamethasone a...	18 Years - 59 Years	Alliance for Clinical Trials in Oncology
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia	NCT00899743	Leukemia	polyacrylamide ... western blottin... immunologic tec... laboratory biom...	56 Years -	SWOG Cancer Research Network
Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML	NCT01849276	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Blastic Phase C... Recurrent Adult... Untreated Adult...	metformin hydro... cytarabine laboratory biom...	18 Years -	Northwestern University
Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission	NCT00045435	Acute Myeloid L... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute...	nonmyeloablativ... fludarabine pho... total-body irra... cyclosporine mycophenolate m... peripheral bloo...	55 Years -	Fred Hutchinson Cancer Center
Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia	NCT00268242	Leukemia	Gemcitabine Hyd... Mitoxantrone Hy...	18 Years -	The Cleveland Clinic
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia	NCT01385150	Leukemia	mutation analys... protein analysi... laboratory biom... liquid chromato... mass spectromet...	17 Years - 60 Years	Eastern Cooperative Oncology Group
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia	NCT00052299	Leukemia	cytarabine etoposide gemtuzumab ozog... idarubicin mitoxantrone hy...	61 Years - 75 Years	European Organisation for Research and Treatment of Cancer - EORTC
Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia	NCT00005801	Leukemia	therapeutic all... peripheral bloo... radiation thera...	55 Years - 74 Years	University of Colorado, Denver
Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia	NCT00027872	Acute Myeloid L... Adult Acute Bas... Adult Acute Eos... Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Cellular Diagno... Untreated Adult...	tipifarnib laboratory biom...	65 Years -	National Cancer Institute (NCI)
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia	NCT00352365	Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult...	lenalidomide	60 Years -	National Cancer Institute (NCI)
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia	NCT02144675	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... Untreated Adult...	choline magnesi... idarubicin cytarabine laboratory biom...	18 Years -	Rutgers, The State University of New Jersey
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia	NCT00528398	Leukemia	cytarabine idarubicin	16 Years - 60 Years	City of Hope Medical Center
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia	NCT02144675	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... Untreated Adult...	choline magnesi... idarubicin cytarabine laboratory biom...	18 Years -	Rutgers, The State University of New Jersey
Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia	NCT00005962	Leukemia	sargramostim cyclophosphamid... cytarabine gemtuzumab ozog... liposomal dauno... topotecan hydro...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia	NCT00003405	Leukemia	recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy...	0 Years - 70 Years	Rush University Medical Center
Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome	NCT00002547	Leukemia Myelodysplastic...	busulfan cyclophosphamid... cyclosporine cytarabine methotrexate allogeneic bone... syngeneic bone ...	- 60 Years	Barbara Ann Karmanos Cancer Institute
AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	NCT01253447	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult...	Akt inhibitor M... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia	NCT00002658	Leukemia Neutropenia	filgrastim amsacrine cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... peripheral bloo... radiation thera...	15 Years -	National Cancer Institute (NCI)
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia	NCT00838240	Leukemia Myelodysplastic...	clofarabine cytarabine idarubicin	18 Years - 60 Years	European Organisation for Research and Treatment of Cancer - EORTC
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission	NCT00454168	Leukemia	PR1 leukemia pe... sargramostim placebo	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia	NCT00006363	Adult Acute Bas... Adult Acute Eos... Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Myelo... de Novo Myelody... Untreated Adult... Untreated Child...	cytarabine daunorubicin hy... etoposide valspodar filgrastim busulfan autologous hema... peripheral bloo... aldesleukin clinical observ... pharmacological...	15 Years - 59 Years	National Cancer Institute (NCI)
Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia	NCT00005962	Leukemia	sargramostim cyclophosphamid... cytarabine gemtuzumab ozog... liposomal dauno... topotecan hydro...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R	NCT00534469	Leukemia	aldesleukin filgrastim busulfan cytarabine etoposide idarubicin autologous hema... bone marrow tra... peripheral bloo... total-body irra...	16 Years - 60 Years	City of Hope Medical Center
Cilengitide in Treating Patients With Acute Myeloid Leukemia	NCT00089388	Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt...	cilengitide	50 Years -	National Cancer Institute (NCI)
flt3L in Treating Patients With Acute Myeloid Leukemia	NCT00006223	Leukemia	recombinant flt...	18 Years -	National Cancer Institute (NCI)
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia	NCT01421875	Leukemia	DNA methylation... RNA analysis gene expression... microarray anal... nucleic acid se... laboratory biom...	61 Years - 120 Years	Eastern Cooperative Oncology Group
Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00814164	Leukemia	clofarabine daunorubicin hy... cytogenetic ana... protein express... immunologic tec... pharmacological...	60 Years - 120 Years	Roswell Park Cancer Institute
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy	NCT01235572	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Previously Trea... Recurrent Adult...	standard follow... medical chart r... quality-of-life...	18 Years - 75 Years	Fred Hutchinson Cancer Center
Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy	NCT02071901	Acute Myeloid L... Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute...	eltrombopag ola...	60 Years -	Case Comprehensive Cancer Center
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia	NCT00898456	Leukemia	gene expression... molecular genet... polymorphism an... protein express... diagnostic labo...	15 Years -	Alliance for Clinical Trials in Oncology
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT02085408	Acute Myeloid L... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult...	Daunorubicin Cytarabine Clofarabine Decitabine Observation Allogeneic hema...	60 Years -	Eastern Cooperative Oncology Group
Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia	NCT01127009	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult...	bortezomib mitoxantrone hy... etoposide cytarabine flow cytometry	18 Years - 70 Years	Case Comprehensive Cancer Center
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia	NCT00003405	Leukemia	recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy...	0 Years - 70 Years	Rush University Medical Center
Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia	NCT00131989	Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... Recurrent Adult...	sorafenib tosyl... pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia	NCT00005801	Leukemia	therapeutic all... peripheral bloo... radiation thera...	55 Years - 74 Years	University of Colorado, Denver
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia	NCT00666588	Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Recurrent Adult... Recurrent Child... Secondary Acute...	idarubicin cytarabine bortezomib etoposide laboratory biom...	1 Year - 21 Years	National Cancer Institute (NCI)
Vorinostat in Treating Patients With Acute Myeloid Leukemia	NCT00305773	Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Pro... Recurrent Adult... Refractory Cyto... Secondary Acute... Untreated Adult...	vorinostat vorinostat	18 Years -	National Cancer Institute (NCI)
AML Therapy With Irradiated Allogeneic Cells	NCT02105116	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... Untreated Adult...	fludarabine pho... cytarabine donor lymphocyt... laboratory biom... G-CSF	18 Years -	Rutgers, The State University of New Jersey
S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML	NCT00085709	Leukemia	gemtuzumab ozog... observation Cytosine arabin... Daunomycin	18 Years - 60 Years	SWOG Cancer Research Network
Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia	NCT01251159	Leukemia	mutation analys... polymerase chai... immunologic tec... laboratory biom...	16 Years - 60 Years	Eastern Cooperative Oncology Group
Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy	NCT00739388	Leukemia	azacytidine	18 Years -	Swiss Group for Clinical Cancer Research
Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	NCT01904643	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult...	lenalidomide mitoxantrone hy... etoposide cytarabine	18 Years -	Stanford University
Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia	NCT00053144	Leukemia	cytarabine irinotecan hydr...	15 Years -	Roswell Park Cancer Institute
Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia	NCT00470197	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Malignant Neopl... Recurrent Adult... Recurrent Adult...	alvocidib cytarabine mitoxantrone hy... pharmacological...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: